Is there any association between the presence of bone disease and cumulative exposure to lead?

Calcified Tissue International

Volumn 63, Issue 5, 1998, Pages 429-432

  Adachi, J D ^b   Arlen, D ^b   Webber, C E ^a   Chettle, D R ^b   Beaumont, L F ^b   Gordon, C L ^b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b NONE

Author keywords

Bone disease; Bone lead content; Cortical bone; Serum lead concentration; Trabecular bone

Indexed keywords

ALKALINE PHOSPHATASE; LEAD; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCANEUS; CONTROLLED STUDY; CORTICAL BONE; ENVIRONMENTAL EXPOSURE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; OSTEOPOROSIS; PAGET BONE DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TIBIA; TRABECULAR BONE;

AGED; ALKALINE PHOSPHATASE; BODY HEIGHT; BODY WEIGHT; BONE AND BONES; BONE DISEASES, METABOLIC; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEAD; LEAD POISONING; MALE; MIDDLE AGED; ONTARIO; OSTEITIS DEFORMANS; OSTEOPOROSIS; PERITONEAL DIALYSIS; REFERENCE VALUES; RENAL DIALYSIS;

EID: 0031717696     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900552     Document Type: Article

References (32)

1. Roy MM, Gordon CL, Beaumont LF, Chettle DR, Webber CE (1997) Further experience with bone lead content measurements in residents of Southern Ontario. App Rad Isotop 48: 391-396
2. 3 and IGF-1. Toxicol Appl Pharmacol 103:281-287
3. Long GJ, Rosen JF, Pounds JG (1990) Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells. Toxicol Appl Pharmacol 106:270-277
4. Long GJ, Rosen JF (1992) Lead perturbs epidermal growth factor (EGF) modulation of intracellular calcium metabolism and collagen synthesis in clonal rat osteoblastic (ROS 17/2.8) cells. Toxicol Appl Pharmacol 114:63-70
5. Sauk JJ, Smith T, Silbergeld EK, Fowler BA, Somerman MJ (1992) Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp 47 production in osteoblast-like ROS 17/2.8 cells. Toxicol Appl Pharmacol 116: 240-247
6. Klein RF, Wiren KM (1993) Regulation of osteoblastic gene expression by lead. Endocrinology 132:2531-2537
7. Hass GM, Brown DVL, Eisenstein R, Hemmens A (1964) Relations between lead poisoning in rabbit and man. Amer J Pathol 45:691-727
8. Anderson C, Danylchuk KD (1977) The effect of chronic low level lead intoxication on the haversian remodelling system in dogs. Lab Invest 37:466-469
9. Anderson C, Danylchuk KD (1980) Haversian bone remodelling rates in the beagle after cessation of exposure to chronic low doses of lead. J Environ Pathol Toxicol 3:413-422
10. 3 metabolism in experimental lead intoxication. Eur J Clin Invest 21:512-520
11. Gruber HE, Sanchez TV, Khalil-Manesh F, Gonick HE (1992) Densitometric evidence for lead-induced osteopenia in the rat. J Bone Miner Res 7(suppl):S174
12. Rosen JF, Chesney RW, Hamstra A, DeLuca HF, Mahaffey KR (1980) Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med 302:1128-1131
13. Markowitz ME, Gundberg CM, Rosen JF (1988) Sequential osteocalcin sampling as a biochemical marker of the success of treatment in moderately lead-poisoned children. Pediatr Res 23:393A
14. Price J, Grudzinski AW, Craswell PW, Thomas BJ (1992) Bone lead measurements in patients with chronic renal disease studied over time. Arch Environ Health 47:330-335
15. Spencer H, O'Sullivan V, Sontag SJ (1995) Exposure to lead, a potentially hazardous toxin: Paget's disease of bone. J Trace Elements Exp Med 8:163-171
16. 3, and radiology in end-stage renal disease. Kidney Int 44:1071-1077
17. Quarles LD, Lobaugh B, Murphy G (1992) Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150
18. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43:436-442
19. Gordon CL, Chettle DR, Webber CE (1993) An improved instrument for the in vivo detection of lead in bone. Br J Ind Med 50:637-641
20. -1 levels of lead in human plasma. J Anal At Spectrom 9:1233-1236
21. Gerhardsson L, Attewell R, Chettle DR, Englyst V, Lundström N-G, Nordberg GF, Nyhlin H, Scott MC, Todd AC (1993) In-vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health 48:147-156
22. Rabinowitz MB, Wetherill GW, Kopple JD (1977) Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58:260-270
23. Steenhout A (1982) Kinetics of lead storage in teeth and bones: an epidemiological approach. Arch Env Health 37: 224-230.
24. Schütz A, Skerfving S, Mattson S, Christoffersson J-O, Ahlgren L (1987) Lead in vertebral bone biopsies from active and retired lead workers. Arch Environ Health 42:340-346
25. Skerfving S, Christoffersson J-O, Schütz A, Welinder H, Spang G, Ahlgren L, Mattsson S (1987) Biological monitoring by in vivo XRF measurements of occupational exposure to lead, calcium and mercury. Biol Trace Elem Res 13:241-251
26. Fleming DEB, Boulay D, Richard NS, Robin J-P, Gordon CL, Webber CE, Chettle DR (1997) Accumulated body burden and endogenous release of lead in employees of a lead smelter. Environ Health Perspect 105:224-233
27. Delmas PD (1990) Biochemical markers of bone turnover for the clinical assessment of metabolic bone diseases. Endocrinol Metab Clin N Am 19:1-18
28. Barker DJP, Chamberlain AT, Detheridge FM, Gardner MJ, Guyer PB (1982) Low lead levels in pagetoid bone. Metab Bone Dis Rel Res 4:243-247
29. Delmas PD (1992) Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 13:S16-S21
30. Laufenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Haas HG (1977) Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 26:589-605
31. Christiansen C, Christensen MS, Larsen NE, Transbøl I (1982) Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early post-menopausal women. J Clin Endocrinol Metab 55:1124-1130
32. Kessler M, Durand PY, Hestin D, Huu TC, Renoult E, Chanliau J, Kaminski P, Duc M (1995) Elevated body lead burden from drinking water in end-stage chronic renal failure. Nephrol Dial Transplant 10:1648-1653